SCHEMBL24675480

SCHEMBL24675480

CC(=O)CCN1CCC(N)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 2/20 0.49
HRH1 P35367 2/20 0.49
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
GNAI3 P08754 2/20 0.37
GNAO1 P09471 2/20 0.37
GNAI1 P63096 2/20 0.37
PAOX Q6QHF9 1/20 0.37
LTA4H P09960 1/20 0.36
ALDH1A1 P00352 3/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
HRH3 Q9Y5N1 1/20 0.34
BCHE P06276 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12635273 0.89 BCHE (0.41) HRH2HRH1POLBHTTSMN1; SMN2
SCHEMBL12635280 0.89 BCHE (0.41) HRH2HRH1POLBHTTSMN1; SMN2
SCHEMBL12635261 0.89 POLB (0.47) HRH2HRH1POLBHTTSMN1; SMN2
SCHEMBL5744835 0.82 HRH2 (0.44) HRH2HRH1POLBHTTSMN1; SMN2
SCHEMBL12226501 0.81 HRH2 (0.44) HRH2HRH1POLBHTTSMN1; SMN2
SCHEMBL5744837 0.81 HRH2 (0.44) HRH2HRH1POLBHTTSMN1; SMN2
SCHEMBL12226499 0.81 HRH2 (0.44) HRH2HRH1POLBHTTSMN1; SMN2
SCHEMBL13993975 0.79 PDCD1 (0.46) POLBHTTSMN1; SMN2PAOXLTA4H
SCHEMBL14520291 0.79 PDCD1 (0.46) POLBHTTSMN1; SMN2PAOXLTA4H
SCHEMBL14197721 0.79 POLB (0.50) POLBHTTSMN1; SMN2PAOXALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022223022-A1 FUSED-RING HETEROCYCLE DERIVATIVE AND MEDICAL APPLICATION THEREOF 四川海思科制药有限公司 2022-10-27 WO disclosed